The vitamin D analogue calcipotriol was introduced in the early 1990s as a topical treatment for mild-to-moderate plaque psoriasis. Since then other vitamin D derivatives have been studied. One systematic review of calcipotriol found that it was at least as effective as potent topical corticosteroids, calcitriol, short-contact anthralin (dithranol) therapy and coal tar. Its main drawback is that it may cause skin irritation. Much less evidence is available for other vitamin D analogues, including tacalcitol and maxacalcitol.
Was this article helpful?
Do You Suffer From the Itching and Scaling of Psoriasis? Or the Chronic Agony of Psoriatic Arthritis? If so you are not ALONE! A whopping three percent of the world’s populations suffer from either condition! An incredible 56 million working hours are lost every year by psoriasis sufferers according to the National Psoriasis Foundation.